Verano Opens Marco Island’s First Cannabis Dispensary, MÜV Marco Island | News

MÜV Marco Island is located off Collier Boulevard, one of the two main access points to the island, on Bald Eagle Drive, a thoroughfare with an average daily traffic of 14,200 vehicles1The dispensary is located in the heart of the shopping district and restaurants of Marco Island, within walking distance of the island’s bustling downtown area

CHICAGO, April 01, 2022 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the opening of Marco Island’s first cannabis dispensary, MÜV Marco Island, the company’s 44th statewide location. MÜV Marco Island, located at 695 Bald Eagle Drive, will celebrate its grand opening on Friday, April 1 at 9 a.m. local time.

As the premier medical cannabis dispensary in the island community of over 15,7002, MÜV Marco Island is located in a popular tourist area. Marco Island, Naples and the Everglades welcomed 175,000 visitors in February 2022 – including 24,000 Floridians – an increase of 10,000 tourists compared to February 20213.

“We are thrilled to open Marco Island’s first cannabis dispensary, where our compassionate team will have the honor of serving a vibrant patient community of area residents and visitors alike,” said John Tipton, President of Verano. . “MÜV Marco Island’s ideal location will complement our nearby MÜV Bonita Springs dispensary, allowing us to adequately serve the growing number of patients and visitors to Marco Island and the Naples area for years to come.”

As a demonstration of their commitment to providing a convenient and reliable experience for Florida patients, MÜV Dispensaries offers online menus for effortless browsing of their extensive selection of award-winning products. For added convenience and accessibility, patients can choose to pre-order at for express in-store pickup.

MÜV offers one-to-one virtual and in-store consultations at no cost to the patient. MÜV’s comprehensive product selection includes edibles, chocolates and lozenges, flowers, pre-rolls, a range of vape pens, concentrates, metered dose inhalers, topicals and oral sprays; as well as patented encapsulating formulations in its EnCaps™ capsules, tinctures, 72 hour transdermal patches and transdermal gels.

For more information on Marco Island’s new medical cannabis dispensary, including hours of operation and available MÜV products, visit

About Verano

Verano is a leading, vertically integrated, multi-state cannabis operator in the United States, dedicated to the continuous improvement of collective well-being by providing responsible access to regulated cannabis products. With a mission to meet vital health and wellness needs, Verano produces a full line of innovative, premium cannabis products sold under its trusted portfolio of consumer brands, including Verano™, Avexia™, Encore™ and MÜV™. Verano’s portfolio encompasses 15 U.S. states, with active operations in 13, including 12 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds and operates dispensaries under retail brands such as Zen Leaf™ and MÜV™, providing a superior cannabis shopping experience in the medical and adult markets. Learn more at


Verano Media Steve Mazeika Director, Communications [email protected] 312-348-4430

Verano Investors Julianna Paterra, CFA Director, Investor Relations [email protected]

Forward-looking statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities laws and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act. . of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or of the current situation, but rather represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and beyond the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “anticipates”, “expects” or “does not expect”, “is expected”, ” budget”, “future”, “planned”, “estimates”, “plans”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of these words and expressions or may contain statements that certain actions, events or results “could”, “could”, “would”, “would” or “would be taken”, “would continue”, “would be achieved” or “would be achieved”. Forward-looking information and forward-looking statements contained herein include, but are not limited to, statements or information regarding the operations of the Company. Forward-looking information and statements involve and are subject to known and unknown assumptions and risks, uncertainties and other factors that may cause the Company’s actual events, results, performance or achievements to differ materially from the events, results, performance, and achievements expressed or implied by the forward-looking information and statements contained herein, including, without limitation, the risk factors discussed in the documents publicly filed by the Company on SEDAR at www. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements contained or referenced herein. , except as may be required under applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by this notice regarding forward-looking information and statements.


1 Source: FL Dept. of Transportation 2 Source: US Census 3 Source: Naples, Marco Island, Everglades Convention & Visitors Bureau

Lynn A. Saleh